每经AI快讯，有投资者在投资者互动平台提问：公司的研发实力很强，浙江又是莹石的主要产区，请 问新和成有无氟化工产品或项目储备？在化工行业将来会有全球首发的材料吗？ 新和成（002001.SZ）2月11日在投资者互动平台表示，公司目前氟化工相关产品主要为全氟己基辛烷、 全氟丁基戊烷。 （文章来源：每日经济新闻） ...

Investment Rating - The report maintains a rating of "Outperform" for the new materials sector, indicating a positive outlook for investment opportunities in this industry [2]. Core Insights - The new materials sector has experienced a decline, with the new materials index dropping by 1.53%, outperforming the ChiNext index by 1.76%. Over the past five trading days, various sub-sectors showed mixed performance, with battery chemicals slightly increasing by 0.09% while semiconductor materials fell by 3.70% [3][17]. - Strong capital expenditure growth is observed in North America, particularly among major cloud service providers like Amazon AWS, Microsoft, Google, and Meta, with a combined capital expenditure exceeding $670 billion in 2026, representing a year-on-year growth of over 60%. This investment is expected to drive demand for AI servers and related materials [6]. Summary by Sections 1. Secondary Market Performance - The new materials sector has seen a decline, with the Shanghai Composite Index and ChiNext Index also experiencing negative movements. The new materials index's performance is highlighted as it has outperformed the ChiNext index [3][13]. 2. Industry Chain Data Tracking - Price tracking for various materials shows fluctuations, with amino acids like valine at 13,850 RMB/ton (-1.42%) and vitamins such as vitamin A at 60,500 RMB/ton (-1.63%). Prices for biodegradable plastics remain stable, indicating a steady market for these materials [4][12]. 3. Industry News - The report emphasizes the importance of AI infrastructure development, which is expected to enhance the demand for high-frequency and high-speed copper-clad laminates and related materials. Companies such as Shengquan Group and Dongcai Technology are highlighted for their potential in the resin sector, while Zhongcai Technology and Honghe Technology are noted for electronic fabrics [6]. 4. Investment Recommendations - The report suggests focusing on upstream material development opportunities, particularly in AI-related sectors, as the demand for advanced materials is anticipated to grow significantly due to the increasing need for AI server infrastructure [5][6].

价格：据Wind及博亚和讯数据，2025年固蛋、液蛋市场均价为21.68、16.49元/公斤，同比+1.6%、 +3.0%，2025Q3以来蛋氨酸价格震荡下行，2月9日固蛋、液蛋市场价格18.50、14.30元/公斤，同比分 别-15.5%、-7.7%，处于1.8%、1.1%的历史分位(2008年8月14日以来)。 智通财经APP获悉，开源证券发布研报称，据百川盈孚数据，2026年1月以来工厂趁下游春节备货挺价 态度强硬，蛋氨酸报价达到18.50元/公斤，期间国内主流工厂给部分客户补单18.0元/吨公斤停止此价格 接单。维生素方面，2025Q4部分大品种厂家持续挺价+渠道商库存偏低+下游备货+出口需求增加等因素 影响下，部分产品价格低位反弹。2月5日新和成饲料级VE50%出口报价上调15%，随后北沙制药VE出 口报价同步上调至7.5美元/公斤，主流厂家对后市多持挺价态度。 开源证券主要观点如下： 蛋氨酸：成本支撑+厂家检修+备货需求，蛋氨酸价格触底反弹 据百川盈孚数据，2026年1月以来工厂趁下游春节备货挺价态度强硬，报价达到18.50元/公斤，期间国 内主流工厂给部分客户补单18.0元/吨公斤停止此价格接单 ...

Group 1 - The core viewpoint of the news is that the Chinese medical device and equipment trading platform has been launched in Tianjin, which aims to facilitate global trade in medical devices and equipment, thereby promoting the export of domestic medical products and enhancing cross-border industrial cooperation [1] - The China International Medical Equipment and Instrument Trading Platform will provide services such as online display of pharmaceutical products, procurement information, policy information collection and publication, and market operation data analysis [1] - The medical industry is experiencing a new high due to the continuous demand for pharmaceuticals and the increasing unmet needs, along with pharmaceutical companies increasing their R&D investments to meet these demands [1] Group 2 - The CSI Medical and Medical Device Innovation Index (931484) has shown a positive performance, with a 0.34% increase, and notable gains in constituent stocks such as Teva Bio and New Hope [1] - The top ten weighted stocks in the CSI Medical and Medical Device Innovation Index account for 63.9% of the index, including companies like WuXi AppTec, Mindray Medical, and Hengrui Medicine [2] - The medical innovation ETF closely tracks the CSI Medical and Medical Device Innovation Index, reflecting the overall performance of profitable and growth-oriented medical and medical device companies [2]

Group 1 - The core viewpoint of the news highlights the growth and investment opportunities in the brain-computer interface (BCI) market, particularly in China, with significant funding and technological advancements being made by domestic companies [1][2] - The China Medical and Medical Device Innovation Index (931484) has shown a positive performance, with a 0.78% increase, and notable gains in constituent stocks such as TeBao Bio and XinHe Cheng [1] - The global brain-computer interface market is projected to reach approximately $2.62 billion in 2024, with an expected growth to $2.94 billion in 2025 and a compound annual growth rate of 17.35% over the next decade [2] Group 2 - The Chinese brain-computer interface market is anticipated to grow from 3.2 billion yuan in 2024 to 6.14 billion yuan by 2028, indicating a strong domestic market potential [2] - Recent funding of 300 million yuan in A+ round financing for ZhiRan Medical will be utilized for large-scale clinical trials and product iterations, marking a significant step in the application of invasive brain-computer interfaces [1] - The top ten weighted stocks in the China Medical and Medical Device Innovation Index account for 63.9% of the index, with companies like WuXi AppTec and Mindray Medical leading the list [2]

Core Insights - The report highlights a rebound in institutional attention towards sectors such as agriculture, defense, and home appliances, indicating a potential shift in investment focus [4][7] - The report discusses the recent refinancing policies aimed at enhancing support for quality listed companies and improving the flexibility of refinancing mechanisms, particularly for technology innovation enterprises [17][20] - The performance of the "Preferred Gold Stock 30" portfolio has consistently outperformed the market, achieving a 21.9% excess return in 2025 compared to the CSI 500 index [13][14] Institutional Research Overview - Institutional research is crucial for investment decision-making, providing timely and multidimensional insights that complement financial information [6] - Recent trends show a decrease in total institutional research frequency across the A-share market, although certain sectors like machinery, electronics, and power equipment remain highly regarded [7][8] Sector-Specific Insights - The agriculture and aquaculture sectors have seen increased research interest, with a notable rise in the number of institutional surveys [8] - The chemical industry, particularly methionine and vitamin markets, is experiencing price rebounds due to cost support and stable demand, with methionine prices reaching 18.50 CNY/kg [29][31] - The electric equipment and new energy sector, represented by companies like Weimais, is benefiting from steady growth in the domestic electric vehicle market and expanding overseas [37][38] Company-Specific Insights - Jerry Holdings is focusing on international expansion and has been frequently surveyed by institutions, indicating strong market interest [10] - Baidu Group is positioned for a significant transformation in AI commercialization, with expectations for revenue growth driven by its cloud and chip businesses [34][36] - Weimais reported a net profit of 5.57 billion CNY in 2025, reflecting a 39.2% year-on-year increase, supported by growth in the electric vehicle sector [37][38]

基础化工 2026 年 02 月 10 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -14% 0% 14% 29% 43% 58% 2025-02 2025-06 2025-10 基础化工 沪深300 相关研究报告 《地产或将复苏，关注化工地产链投 资机会—行业周报》-2026.2.8 《原料价格走高+供需格局改善，本周 对硝基氯化苯、己二酸等价格上行明 显—行业周报》-2026.2.1 《水俣公约等多重因素加快氯碱落后 产能退出，行业有望迎来历史性新变 化—行业点评报告》-2026.1.28 成本支撑、需求稳增，蛋氨酸、VE 价格底部反弹 ——维生素氨基酸行业点评报告 金益腾（分析师） 徐正凤（分析师） jinyiteng@kysec.cn 证书编号：S0790520020002 xuzhengfeng@kysec.cn 证书编号：S0790524070005 蛋氨酸：成本支撑+厂家检修+备货需求，蛋氨酸价格触底反弹 据百川盈孚数据，2026 年 1 月以来工厂趁下游春节备货挺价态度强硬，报价达 到 18.50 元/公斤，期间国内主流工厂给部分客户补单 18.0 元/吨公斤停止此价格 接单。据饲 ...

Core Viewpoint - Tianjin's Development and Reform Commission has released a list of 1,112 key projects with a total investment of 1.82 trillion yuan, aiming to support high-quality development and achieve a strong start for the 14th Five-Year Plan [1][13]. Group 1: Investment and Project Overview - This year, Tianjin has arranged a total investment of 1.4 trillion yuan for 824 key construction projects, with an annual planned investment of 202.19 billion yuan and 288 key reserve projects totaling 422.47 billion yuan [1][13]. - During the 14th Five-Year Plan period, cumulative investment in key projects reached 1.19 trillion yuan, significantly supporting the city's stable economic growth [2][14]. Group 2: Focus Areas for Development - Key projects this year focus on the deep integration of technological innovation and industrial innovation, fostering new growth drivers, and implementing an innovation-driven development strategy [3][15]. - The emphasis is on intelligent and green integration in manufacturing, strengthening new industrial clusters in sectors such as aerospace, biomedicine, circular economy, and new energy materials [3][15]. - Modern service industry development is prioritized to enhance consumption potential and improve the quality and diversity of services [3][15]. Group 3: Major Engineering Initiatives - Eight major engineering initiatives have been proposed, including promoting coordinated development in the Beijing-Tianjin-Hebei region, advancing high-level technological self-reliance, and enhancing modern service industry capabilities [5][17]. - The focus is on strategic projects that have significant investment scales and strong driving effects, with 300 projects selected for key promotion [5][17]. Group 4: Infrastructure and Urban Development - Infrastructure projects include the acceleration of subway line constructions and improvements in urban drainage and heating systems to enhance urban resilience [8][21]. - Urban renewal projects are underway to optimize urban functionality and improve the quality of life for residents [8][21]. Group 5: Social Welfare and Rural Development - Initiatives are being implemented to improve rural living conditions, develop modern agriculture, and enhance social security systems to increase public satisfaction and well-being [4][16]. - The focus is on creating demonstration bases for rural revitalization and promoting high-value rural industries [9][22]. Group 6: Project Lifecycle and Support - The city will enhance services for key enterprises and projects, ensuring timely commencement and acceleration of construction [11][25]. - Comprehensive support will be provided for planning, land use, and funding to facilitate project development and investment quality improvement [11][25].

Investment Rating - The report maintains an "Optimistic" rating for the chemical industry [2][3] Core Insights - The report highlights an upward trend in the dye, PVA, and vitamin sectors, with price increases expected post-holiday. It emphasizes the importance of positioning in the spring chemical sector [2][3] - Oil prices are expected to remain in a relatively loose range, supported by a stronger bottom, with Brent crude projected between $55-70 per barrel. Coal prices are stabilizing, and natural gas costs are anticipated to decline due to increased export facilities in the U.S. [2][3] - The report suggests focusing on specific sectors such as textiles, agriculture, exports, and beneficiaries of "anti-involution" policies for investment opportunities [2][3] Summary by Sections Industry Dynamics - Current macroeconomic judgment indicates that oil supply is slowing due to OPEC+ production delays and peak shale oil output. Demand is stabilizing with global economic improvements, leading to a forecast of stable oil demand [3][4] - The chemical industry is experiencing a recovery phase, with PPI showing a slight increase and manufacturing PMI at 49.3%, indicating some volatility in manufacturing operations [4] Investment Analysis - The report recommends investments in the textile chain, agricultural chain, export chain, and sectors benefiting from anti-involution policies. Specific companies to watch include: - Textiles: Lu Xi Chemical, Tongkun Co., Rongsheng Petrochemical, Hengli Petrochemical - Agriculture: Hualu Hengsheng, Baofeng Energy, Yuntianhua, Xingfa Group - Exports: Juhua Co., Sanmei Co., Wanhu Chemical, and others [2][3] - Key materials for growth include semiconductor materials, panel materials, and biobased materials, with specific companies highlighted for each category [2][3] Key Company Valuations - The report provides a valuation table for key companies, indicating their market capitalization and projected earnings for 2024-2027, with recommendations for "Increase" or "Buy" ratings for several firms [15][16]

Investment Rating - The report maintains an "Optimistic" rating for the chemical industry [2][3] Core Insights - The chemical macroeconomic outlook indicates a stable increase in oil demand due to global economic recovery, with Brent crude oil expected to remain in the range of $55-70 per barrel [2][3] - The dye, PVA, and vitamin sectors are experiencing upward trends, with price increases anticipated post-holiday, highlighting the importance of positioning in the spring chemical sector [2][3] - The report suggests focusing on specific companies within the textile, agricultural, export, and "anti-involution" sectors for investment opportunities [2][3] Summary by Relevant Sections Chemical Macro Outlook - Oil supply is constrained due to OPEC+ production delays and peak shale oil output, while demand is stabilizing with tariff adjustments and economic improvements [2][3] - Coal prices are expected to stabilize at a long-term bottom, and natural gas costs may decrease as the U.S. accelerates export facility construction [2][3] Price Trends and Recommendations - Dye prices are expected to rise significantly, with companies like Zhejiang Longsheng and Runtu Co. recommended for investment [2][3] - PVA prices have increased from 9,530 CNY/ton to 10,244 CNY/ton, indicating further upward potential, with a focus on Anhui Wuhua [2][3] - Vitamin E prices are projected to rise post-holiday due to production halts during the Chinese New Year, with New Hope Liuhe recommended [2][3] Investment Strategy - The report recommends a diversified investment approach across four main chains: textile, agricultural, export, and sectors benefiting from "anti-involution" policies [2][3] - Key companies to watch include: - Textile: LUXI Chemical, Tongkun Co., and Hengli Petrochemical - Agricultural: Hualu Hengsheng, Baofeng Energy, and Yuntianhua - Export-related chemicals: Juhua Co., Wanhua Chemical, and leading titanium dioxide producers [2][3] Growth Focus - Emphasis on self-sufficiency in key materials, particularly in semiconductor and panel materials, with companies like Yake Technology and Dingsheng Co. highlighted [2][3]